Literature DB >> 34100901

Blueprint for the discovery of biomarkers of toxicity and efficacy for CAR T cells and T-cell engagers.

Sophie Paczesny1, Marcelo C Pasquini2, Steven Z Pavletic3, Amit Agarwal4, Stephen Spellman5, Leslie Kean6, Chantale Bernatchez7, Juliane Gust8, Verena Staedtke9, Miguel-Angel Perales10.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34100901      PMCID： PMC8238483          DOI： 10.1182/bloodadvances.2021004604

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  7 in total

Review 1.  Biomarker Qualification: Toward a Multiple Stakeholder Framework for Biomarker Development, Regulatory Acceptance, and Utilization.

Authors:  S Amur; L LaVange; I Zineh; S Buckman-Garner; J Woodcock
Journal:  Clin Pharmacol Ther       Date:  2015-06-06       Impact factor: 6.875

Review 2.  Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.

Authors:  Tania Jain; Merav Bar; Ankit J Kansagra; Elise A Chong; Shahrukh K Hashmi; Sattva S Neelapu; Michael Byrne; Elad Jacoby; Aleksandr Lazaryan; Caron A Jacobson; Stephen M Ansell; Farrukh T Awan; Linda Burns; Veronika Bachanova; Catherine M Bollard; Paul A Carpenter; John F DiPersio; Mehdi Hamadani; Helen E Heslop; Joshua A Hill; Krishna V Komanduri; Craig A Kovitz; Hillard M Lazarus; Justin M Serrette; Mohamad Mohty; David Miklos; Arnon Nagler; Steven Z Pavletic; Bipin N Savani; Stephen J Schuster; Mohamed A Kharfan-Dabaja; Miguel-Angel Perales; Yi Lin
Journal:  Biol Blood Marrow Transplant       Date:  2019-08-22       Impact factor: 5.742

Review 3.  Enrollment of Racial Minorities in Clinical Trials: Old Problem Assumes New Urgency in the Age of Immunotherapy.

Authors:  Bassel Nazha; Manoj Mishra; Rebecca Pentz; Taofeek K Owonikoko
Journal:  Am Soc Clin Oncol Educ Book       Date:  2019-05-17

4.  Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT).

Authors:  Ankit J Kansagra; Noelle V Frey; Merav Bar; Theodore W Laetsch; Paul A Carpenter; Bipin N Savani; Helen E Heslop; Catherine M Bollard; Krishna V Komanduri; Dennis A Gastineau; Christian Chabannon; Miguel A Perales; Michael Hudecek; Mahmoud Aljurf; Leslie Andritsos; John A Barrett; Veronika Bachanova; Chiara Bonini; Armin Ghobadi; Saar I Gill; Joshua A Hill; Saad Kenderian; Partow Kebriaei; Arnon Nagler; David Maloney; Hien D Liu; Nirali N Shah; Mohamed A Kharfan-Dabaja; Elizabeth J Shpall; Ghulam J Mufti; Laura Johnston; Elad Jacoby; Ali Bazarbachi; John F DiPersio; Steven Z Pavletic; David L Porter; Stephan A Grupp; Michel Sadelain; Mark R Litzow; Mohamad Mohty; Shahrukh K Hashmi
Journal:  Bone Marrow Transplant       Date:  2019-05-15       Impact factor: 5.483

Review 5.  ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells.

Authors:  Daniel W Lee; Bianca D Santomasso; Frederick L Locke; Armin Ghobadi; Cameron J Turtle; Jennifer N Brudno; Marcela V Maus; Jae H Park; Elena Mead; Steven Pavletic; William Y Go; Lamis Eldjerou; Rebecca A Gardner; Noelle Frey; Kevin J Curran; Karl Peggs; Marcelo Pasquini; John F DiPersio; Marcel R M van den Brink; Krishna V Komanduri; Stephan A Grupp; Sattva S Neelapu
Journal:  Biol Blood Marrow Transplant       Date:  2018-12-25       Impact factor: 5.742

Review 6.  Cancer Moonshot Immuno-Oncology Translational Network (IOTN): accelerating the clinical translation of basic discoveries for improving immunotherapy and immunoprevention of cancer.

Authors:  Ananth Annapragada; Andrew Sikora; Catherine Bollard; Jose Conejo-Garcia; Conrad Russell Cruz; Shadmehr Demehri; Michael Demetriou; Levon Demirdjian; Lawrence Fong; Mary Horowitz; Alan Hutson; Kathryn Kadash-Edmondson; Donald Kufe; Steven Lipkin; Song Liu; Claire McCarthy; Martin Morgan; Zachary Morris; Yang Pan; Marcelo Pasquini; Stephen Schoenberger; Eliezer Van Allen; Eduardo Vilar; Yi Xing; Wenjuan Zha; Adekunle Odunsi
Journal:  J Immunother Cancer       Date:  2020-06       Impact factor: 13.751

7.  Isabl Platform, a digital biobank for processing multimodal patient data.

Authors:  Juan S Medina-Martínez; Juan E Arango-Ossa; Max F Levine; Yangyu Zhou; Gunes Gundem; Andrew L Kung; Elli Papaemmanuil
Journal:  BMC Bioinformatics       Date:  2020-11-30       Impact factor: 3.169
  7 in total
  3 in total

Review 1.  Role of CD19 Chimeric Antigen Receptor T Cells in Second-Line Large B Cell Lymphoma: Lessons from Phase 3 Trials. An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.

Authors:  Miguel-Angel Perales; Larry D Anderson; Tania Jain; Saad S Kenderian; Olalekan O Oluwole; Gunjan L Shah; Jakub Svoboda; Mehdi Hamadani
Journal:  Transplant Cell Ther       Date:  2022-06-26

2.  An overview of multiplexed analyses of CAR T-cell therapies: insights and potential.

Authors:  Brittany Paige DePriest; Noah Vieira; Alan Bidgoli; Sophie Paczesny
Journal:  Expert Rev Proteomics       Date:  2021-10-17       Impact factor: 4.250

Review 3.  Cytokine Release Syndrome and Associated Acute Toxicities in Pediatric Patients Undergoing Immune Effector Cell Therapy or Hematopoietic Cell Transplantation.

Authors:  Susanne H C Baumeister; Gopi S Mohan; Alaa Elhaddad; Leslie Lehmann
Journal:  Front Oncol       Date:  2022-03-24       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.